×
Vaso Net Profit Margin 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Vaso net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
View More
Vaso Net Profit Margin 2010-2024 | VASO
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Profit Margins
Gross Margin
Operating Margin
EBITDA Margin
Pre-Tax Margin
Net Margin
Vaso net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$200.4B
Intuitive Surgical (ISRG)
$186.8B
Edwards Lifesciences (EW)
$44.1B
Alcon (ALC)
$41.8B
IQVIA Holdings (IQV)
$35.8B
IDEXX Laboratories (IDXX)
$33.8B
DexCom (DXCM)
$31.3B
Waters (WAT)
$21.9B
STERIS (STE)
$20.5B
SONOVA HOLDING (SONVY)
$19.7B
Hologic (HOLX)
$16.3B
Fresenius Medical Care AG KGaA (FMS)
$13.4B
Sysmex ADR (SSMXY)
$11.8B
Globus Medical (GMED)
$11.3B
Penumbra (PEN)
$9.3B
Masimo (MASI)
$9.1B
Glaukos (GKOS)
$8.3B
Teleflex (TFX)
$8.3B
Integer Holdings (ITGR)
$4.5B
PROCEPT BioRobotics (PRCT)
$4.2B
Inari Medical (NARI)
$3.2B
Veracyte (VCYT)
$3.2B
LivaNova (LIVN)
$2.6B
Nihon Kohden (NHNKY)
$2.4B
Tandem Diabetes Care (TNDM)
$2.4B
Elekta AB (EKTAY)
$2.1B
TransMedics (TMDX)
$2.1B
Integra LifeSciences Holdings (IART)
$1.7B
RxSight (RXST)
$1.4B
Alphatec Holdings (ATEC)
$1.3B